GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Other Stockholders Equity

CLPBY (Coloplast AS) Other Stockholders Equity : $346 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Other Stockholders Equity?

Coloplast AS's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $346 Mil.

Coloplast AS's quarterly Other Stockholders Equity declined from Mar. 2024 ($-51 Mil) to Jun. 2024 ($-191 Mil) but then increased from Jun. 2024 ($-191 Mil) to Sep. 2024 ($346 Mil).

Coloplast AS's annual Other Stockholders Equity declined from Sep. 2022 ($358 Mil) to Sep. 2023 ($349 Mil) and declined from Sep. 2023 ($349 Mil) to Sep. 2024 ($346 Mil).


Coloplast AS Other Stockholders Equity Historical Data

The historical data trend for Coloplast AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Other Stockholders Equity Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 387.97 402.81 357.86 349.04 345.79

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 349.04 -151.87 -51.31 -190.95 345.79

Coloplast AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Coloplast AS Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Q1 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S to Acquire Atos Medical Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual Deep-Dive Sessions Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024